Treating prostate cancer with immunotherapy is currently difficult to do. But preliminary results from a first in-human phase 1 trial using a chimeric antigen receptor (CAR) T cell therapy developed...

Our thought leaders — under the leadership of Marcel van den Brink, M.D., Ph.D., president of City of Hope Los Angeles and City of Hope National Medical Center and...

City of Hope® researchers will present more than 70 abstracts and sessions on innovative clinical trial results, breakthrough diagnostic techniques and advances in treatment options, as well as share their...

Marcel van den Brink, M.D., Ph.D., has always followed his gut. He trailed it into medicine, then oncology. Later, he trusted his innate instincts when deciding to focus on...

According to preclinical research published online today in Cell, one of the world’s premier scientific journals, researchers at City of Hope® have discovered that a type of immune cell...

As the newly appointed chief of the Division of Breast Surgery in the Department of Surgery, Veronica Jones, M.D., City of Hope continues to seek out the latest advancements...

Physicians and scientists with City of Hope® presented data on potential new treatment options for blood cancers at this year’s American Society of Hematology (ASH) conference in San Diego, California...

“I’m relentless. I’m a ‘go-go-go’ person!”Alisa Secaida learned early on how to compete, how to keep looking forward despite setbacks and how to fight the righteous fight. Her “get-it-done”...

An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compared to standard of...

Surgical oncologist Jamie Rand, M.D., has experienced the toll of cancer in a deeply personal way. Four years ago, she lost her mother to a rare form of the...